NMT inhibitor treatment of a senescence-associated disease or disorder of the liver
AssigneesImperial College Innovations Limited, United Kingdom Research and Innovation
InventorsEdward Tate, Wouter Kallemeijn, Jesus Gil, Domhnall McHugh
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of prophylaxis or treatment of a senescence-associated disease or disorder by administering to a subject in need thereof, a therapeutically effective amount of a NMT inhibitor.
Claims13
A method of treatment of a senescence-associated disease or disorder by administering to a subject in need thereof, a therapeutically effective amount of a NMT inhibitor, wherein the senescence-associated disease or disorder is a liver-related disease or disorder, wherein the senescence-associated disease or disorder is not cancer.
A method of treatment of a senescence-associated disease or disorder by administering to a subject in need thereof, a therapeutically effective amount of a pharmaceutical composition comprising a NMT inhibitor or a pharmaceutically acceptable salt and/or solvate thereof, wherein the senescence-associated disease or disorder is a liver-related disease or disorder, wherein the senescence-associated disease or disorder is not cancer.
Dependencies are inferred from the claim text.